Search

everythinglearnresearchcommunity

for

Search:↓

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Anti-androgen drugs can treat conditions like prostate cancer and male pattern baldness by blocking effects of testosterone and DHT.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Analog 23 is a promising compound for prostate cancer treatment.

Antiandrogen therapy, like cyproterone acetate, effectively treats acne, hirsutism, and hair loss.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Researchers made two new compounds that could be used for medicine.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.